Do high levels of antistreptokinase limit the efficacy of streptokinase in patients with myocardial infarction?

<p><strong>BACKGROUND</strong>: Antistreptokinase antibody in serum of people who had been exposed to streptococcal infections may interfere with thrombolytic effects of streptokinase. Streptokinase is the only thrombolytic medication in Iran, and is the first line treatment in myo...

Full description

Bibliographic Details
Main Authors: Hassan Shemirani, Abbass Rezaie, Saeed Matinkhah, Farzad Arizi
Format: Article
Language:English
Published: Vesnu Publications 2012-03-01
Series:ARYA Atherosclerosis
Online Access:http://arya.mui.ac.ir/index.php/arya/article/view/397